生物统计学
科学的研究计划和数据分析法。
We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
科学的研究计划和数据分析法。
我们的生物统计学家与医学编辑和科学专家合作，确保在研究计划阶段的取得积极临床试验结果。OCT生物统计学专家负责样本量计算、研究方案准备，还为复杂的统计法和临床开发策略提供支持。此外，他们还为全球监管机构的会议代表提供监管指导。
鉴于数据管理和生物统计是临床试验中最重要的部分，因此，我们高度重视选择最先进的解决方案和创新方法，以提高效率、降低开发成本和预测风险。
克里斯蒂娜·邦达列娃
生物统计学负责人
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.